Clinical Trial Update: A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating EMB-001, a metyrapone and oxazepam combination, for Cocaine Use Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• EMB-001 (Metyrapone/Oxazepam combination)
• Metyrapone (Metyrapone)
• OXAZEPAM (OXAZEPAM)

Snippet

Sponsor: Embera NeuroTherapeutics, Inc. | Conditions: Cocaine Use Disorder | Phase 1 | Status: COMPLETED